A Facial Microbiome Map Needs More Than an Average
A small proof-of-concept study measured microbial abundance across facial sites and mapped the spaces between them. Its value lies in the measurement method, not a product-efficacy claim.
One face, different local measurements
Sampling the cheek or forehead alone cannot describe every part of a face. In a 2026 Journal of Investigative Dermatology proof-of-concept study, researchers measured microbes at multiple facial sites and used spatial interpolation to display estimated abundance between those sites. The resulting map is a model built from samples, not a direct measurement of every point on the skin. [1]
The study enrolled five self-reported White women aged 25–50. Researchers sampled up to 25 positions on one half of each face and used a quantitative PCR platform to measure the absolute abundance of 35 microbial species or genera. Droplet digital PCR provided a validation check. The small, homogeneous group matters when interpreting the results. [1]
Location changes what the data say
Within this group, Cutibacterium acnes was dense at the central chin, temple, nose and nasolabial fold, but relatively sparse on the oily forehead. Malassezia restricta was more abundant on the forehead than below the eye. These are observed spatial patterns; they do not establish that one microbe caused a skin condition or that an ingredient changed the microbiome. [1]
The researchers also explored a smaller sampling plan. Their model retained predictive accuracy with nine selected sites in this dataset, while a separate modeling-free approach suggested 15 sites for comprehensive mapping. Neither number should become a universal sampling rule from a five-person study. [1]
Better questions for a product study
The useful lesson is methodological. Before comparing a treatment with a control, a team must decide which facial sites to sample, whether it needs absolute or relative abundance, and how to handle variation between people. A colorful map alone is not evidence of a product benefit. The method can help frame a stronger study, but a specific product would still need its own controlled measurements and outcomes.